title: [The incidence, features of the course, and treatment of arterial hypertension in patients with prostate hyperplasia].
abstract: In 144 middle-aged and elderly male subjects with benign prostate hyperplasia, a study was made into incidence and course features of concomitant arterial hypertension (AH). AH has been proved to be encountered in 144 percent of patients with benign hyperplasia of the prostate. It has been ascertained that in 84% of patients, irritative and obstructive symptoms related to benign hyperplasia of the prostate adversely affect the course of concomitant arterial hypertension. Striking reduction of manifestations of benign prostate hyperplasia-related irritative and obstructive symptoms using cardura, a selective alpha-adrenoblocker, has come to significantly enhance efficiency of treatment of concurrent AH.
authors.forename: M I
authors.initials: MI
authors.lastname: Ukhal'
authors.forename: V V
authors.initials: VV
authors.lastname: Strashnyĭ
authors.forename: G M
authors.initials: GM
authors.lastname: Ukhal'
authors.forename: M V
authors.initials: MV
authors.lastname: Shumilin
mesh_terms: D000317:Adrenergic alpha-Antagonists / Q000627:therapeutic use*; D000368:Aged; D001794:Blood Pressure / Q000187:drug effects / Q000502:physiology; D004231:Diuresis / Q000187:drug effects / Q000502:physiology; D017292:Doxazosin / Q000627:therapeutic use*; D006339:Heart Rate / Q000187:drug effects / Q000502:physiology; D006801:Humans; D006973:Hypertension / Q000150:complications / Q000188:drug therapy / Q000453:epidemiology / Q000503:physiopathology*; D015994:Incidence; D008297:Male; D008875:Middle Aged; D011470:Prostatic Hyperplasia / Q000150:complications*; D011788:Quality of Life; D012189:Retrospective Studies
chemical_list: D000317:Adrenergic alpha-Antagonists; D017292:Doxazosin